Cancer of the Colon Clinical Trial
Official title:
Test of CD47-SIRPα Inhibitors on the Immune Microenvironment Colon Cancer
Our goal is to create novel CD47-SIRPα inhibitors using small molecules to reverse TAM-mediated immune suppression and restore anti-tumor immunity in CRCs. Our program uses structure-based drug design to create selective and potent small molecule inhibitors of SIRPα-CD47 to target the tumor microenvironment with greater efficacy and lower toxicity than CD47-targeting antibodies. . In order to study the activity of CD47-SIRPα inhibitors on the immune microenvironment of tumors, we propose to use organoids derived from biopsies of patients with colon cancer. Tumoroids preserve the patient's tumor stroma (including myeloid cells) and provide an accurate in vitro model of complex tumor immune interaction for the evaluation of immunotherapies.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03068052 -
Behavioral Economic Incentives and Cancer Health Risk Assessment
|
N/A | |
| Active, not recruiting |
NCT03446157 -
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
|
Phase 2 | |
| Completed |
NCT01287130 -
AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05179837 -
Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps
|
N/A | |
| Completed |
NCT02929186 -
Opt-In Versus Opt-Out for Colorectal Cancer Screening Outreach
|
N/A | |
| Completed |
NCT02660671 -
Behavioral Economic Approaches to Increase Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT03072095 -
Colorectal Cancer Screening in a Community Health Setting
|
N/A |